RELENZA (Dispensing Solutions Inc.)
Welcome to the PulseAid listing for the RELENZA drug offered from Dispensing Solutions Inc.. This Neuraminidase Inhibitor [EPC],Neuraminidase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Dispensing Solutions Inc. |
NON-PROPRIETARY NAME: | zanamivir |
SUBSTANCE NAME: | ZANAMIVIR |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Neuraminidase Inhibitor [EPC],Neuraminidase Inhibitors [MoA] |
ROUTE: | RESPIRATORY (INHALATION) |
DOSAGE FORM: | POWDER |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2002-12-22 |
END MARKETING DATE: | 0000-00-00 |
RELENZA HUMAN PRESCRIPTION DRUG Details:
Item Description | RELENZA from Dispensing Solutions Inc. |
LABELER NAME: | Dispensing Solutions Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 5(mg/1) |
START MARKETING DATE: | 2002-12-22 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 68258-3030_342b7e19-49d6-4d0b-950a-cc00f4b79924 |
PRODUCT NDC: | 68258-3030 |
APPLICATION NUMBER: | NDA021036 |
Other ZANAMIVIR Pharmaceutical Manufacturers / Labelers: